Biokinetics and effects of barium sulfate nanoparticles

DSpace/Manakin Repository

Biokinetics and effects of barium sulfate nanoparticles

Citable link to this page


Title: Biokinetics and effects of barium sulfate nanoparticles
Author: Konduru, Nagarjun; Keller, Jana; Ma-Hock, Lan; Gröters, Sibylle; Landsiedel, Robert; Donaghey, Thomas C; Brain, Joseph D; Wohlleben, Wendel; Molina, Ramon M

Note: Order does not necessarily reflect citation order of authors.

Citation: Konduru, Nagarjun, Jana Keller, Lan Ma-Hock, Sibylle Gröters, Robert Landsiedel, Thomas C Donaghey, Joseph D Brain, Wendel Wohlleben, and Ramon M Molina. 2014. “Biokinetics and effects of barium sulfate nanoparticles.” Particle and Fibre Toxicology 11 (1): 55. doi:10.1186/s12989-014-0055-3.
Full Text & Related Files:
Abstract: Background: Nanoparticulate barium sulfate has potential novel applications and wide use in the polymer and paint industries. A short-term inhalation study on barium sulfate nanoparticles (BaSO4 NPs) was previously published [Part Fibre Toxicol 11:16, 2014]. We performed comprehensive biokinetic studies of 131BaSO4 NPs administered via different routes and of acute and subchronic pulmonary responses to instilled or inhaled BaSO4 in rats. Methods: We compared the tissue distribution of 131Ba over 28 days after intratracheal (IT) instillation, and over 7 days after gavage and intravenous (IV) injection of 131BaSO4. Rats were exposed to 50 mg/m3 BaSO4 aerosol for 4 or 13 weeks (6 h/day, 5 consecutive days/week), and then gross and histopathologic, blood and bronchoalveolar lavage (BAL) fluid analyses were performed. BAL fluid from instilled rats was also analyzed. Results: Inhaled BaSO4 NPs showed no toxicity after 4-week exposure, but a slight neutrophil increase in BAL after 13-week exposure was observed. Lung burden of inhaled BaSO4 NPs after 4-week exposure (0.84 ± 0.18 mg/lung) decreased by 95% over 34 days. Instilled BaSO4 NPs caused dose-dependent inflammatory responses in the lungs. Instilled BaSO4 NPs (0.28 mg/lung) was cleared with a half-life of ≈ 9.6 days. Translocated 131Ba from the lungs was predominantly found in the bone (29%). Only 0.15% of gavaged dose was detected in all organs at 7 days. IV-injected 131BaSO4 NPs were predominantly localized in the liver, spleen, lungs and bone at 2 hours, but redistributed from the liver to bone over time. Fecal excretion was the dominant elimination pathway for all three routes of exposure. Conclusions: Pulmonary exposure to instilled BaSO4 NPs caused dose-dependent lung injury and inflammation. Four-week and 13-week inhalation exposures to a high concentration (50 mg/m3) of BaSO4 NPs elicited minimal pulmonary response and no systemic effects. Instilled and inhaled BaSO4 NPs were cleared quickly yet resulted in higher tissue retention than when ingested. Particle dissolution is a likely mechanism. Injected BaSO4 NPs localized in the reticuloendothelial organs and redistributed to the bone over time. BaSO4 NP exhibited lower toxicity and biopersistence in the lungs compared to other poorly soluble NPs such as CeO2 and TiO2. Electronic supplementary material The online version of this article (doi:10.1186/s12989-014-0055-3) contains supplementary material, which is available to authorized users.
Published Version: doi:10.1186/s12989-014-0055-3
Other Sources:
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at
Citable link to this page:
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)


Search DASH

Advanced Search